Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

NCT02157324

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Columbus, Ohio, United States

Research Site Hermitage, Tennessee, United States

Research Site Fort Worth, Texas, United States

View Trial Details

Active, Not Recruiting

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

NCT04892667

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: Cardiology department Paris, France

View Trial Details

Active, Not Recruiting

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

NCT02790515

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +32 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02734771

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Active, Not Recruiting

Health Surveillance at University of Applied Science Hamburg (HAW)

NCT07089914

Conditions: Anxiety, Anxiety Acute, Anxiety Depression, +24 more
Locations: Hamburg University of Applied Sciences/Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg) Hamburg, Germany

View Trial Details

Active, Not Recruiting

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

NCT03684889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Muscle Dysfunction in Patients With Haematological Diseases

NCT05150561

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

NCT04635189

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Active, Not Recruiting

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

NCT00923013

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients

NCT04124497

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chromosome 17 deletion, +14 more
Locations: AOU Ospedali Riuniti Umberto I Ancona, Italy

Policlinico-Università degli Studi Bari, Italy

Ospedali Riuniti Bergamo, Italy

Policlinico S. Orsola Bologna, Italy

View all 15 locations

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions